Valeant Pharmaceuticals International has acquired Lawrenceville, New Jersey-based Aton Pharma, a specialty pharmaceutical company focused on ophthalmology and certain orphan drug indications.
Subscribe to our email newsletter
The acquisition of Aton follows a number of recent acquisitions, including Brazil’s Instituto Terapeutico Delta, in March, and the April acquisition of an unnamed Brazilian company and Canada’s Vital Science Corp.
Valeant Pharmaceuticals International is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology and dermatology.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.